Evolving treatments in retinal surgery

Ms Evgenia Anikina was educated in Cambridge, gaining a first class degree and consequently completed her specialist ophthalmology training in London. She undertook two surgical retinal fellowships and a medical retina fellowship at Moorfields Eye Hospital prior to being appointed as a Consultant Vitreoretinal Surgeon at the Royal Berkshire NHS Trust.

She has been the recipient of a number of prizes and awards and has held several additional roles, including being a member of a medical ethics committee, serving as a medical representative for Great Britain for an international sporting federation and having a position on the Council of the Ophthalmology Section of the RSM.

She is passionate about education and has been involved extensively with teaching and training. This experience has included a College Supervisor role at the University of Cambridge, serving on the clinical skills faculty for the RCOphth and being a College examiner.

James Bainbridge is a surgeon-scientist developing innovative gene and cell therapies for blinding eye disease. He has led the translation of gene therapies from proof of concept in experimental models to clinical trials for the benefit of people affected by inherited blindness. In 2007 he performed the pioneering world's first gene therapy for inherited eye disease, improving sight in adults and children (Bainbridge et al NEJM 2008). In 2018 he was a recipient of the €1m Champalimaud Vision Award, the World’s largest prize in vision research.